Trials / Completed
CompletedNCT01609400
An Extension of CTN 31GB0607 to Evaluate Long Term Safety of NASHA Treatment in the Breast
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 11 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- Female
- Age
- 25 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The study evaluates degradation of NASHA in breast 4 and 6 years post treatment, long term safety and evaluation if a satisfactory breast cancer screening can be performed in subjects treated with NASHA-gel in breast. An independent evaluation of the aesthetic changes is also performed.
Conditions
Timeline
- Start date
- 2011-12-01
- Primary completion
- 2013-08-01
- Completion
- 2013-08-01
- First posted
- 2012-06-01
- Last updated
- 2022-08-25
Source: ClinicalTrials.gov record NCT01609400. Inclusion in this directory is not an endorsement.